XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Series B Convertible Preferred Stock
Series A-1 Convertible Preferred Stock
Series A Convertible Preferred Stock
Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury stock (in shares)   31,000            
Balance at the beginning (in shares) at Dec. 31, 2020         572,465 100,365 618,182  
Balance at the beginning at Dec. 31, 2020         $ 7,999,997 $ 561,041 $ 2,612,038  
Convertible preferred Stock                
Conversion of redeemable convertible preferred stock into common stock upon initial public offering         $ (7,999,997) $ (561,041) $ (2,612,038)  
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)         (572,465) (100,365) (618,182)  
Balance at the beginning (in shares) at Dec. 31, 2020 936,213              
Balance at the beginning at Dec. 31, 2020 $ 94 $ (172) $ 1,779,698 $ (29,057,587)       $ (27,277,967)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock upon initial public offering $ 129   11,172,947         11,173,076
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) 1,291,012              
Conversion of principal and accrued interest of convertible notes and bridge notes into common stock upon initial public offering $ 205   16,392,139         16,392,344
Conversion of principal and accrued interest of convertible notes and bridge notes into common stock upon initial public offering (in shares) 2,049,043              
Issuance of common stock in connection with public offering $ 225   17,999,775         18,000,000
Issuance of common stock in connection with public offering (in shares) 2,250,000              
Offering costs in connection with public offering     (2,339,816)         (2,339,816)
Issuance of common stock in connection with public offering over-allotment option exercise $ 34   2,497,467         2,497,501
Issuance of common stock in connection with public offering over-allotment option exercise (in shares) 337,500              
Issuance of common stock in connection with private placement $ 175   20,999,813         20,999,988
Issuance of common stock in connection with private placement (in shares) 1,749,999              
Transaction costs in connection with private placement     (1,434,999)         (1,434,999)
Issuance of common stock in exchange for services     12,500         $ 12,500
Issuance of common stock in exchange for services (in shares) 2,000             2,000
Issuance of common stock through exercise of stock options $ 5   58,643         $ 58,648
Issuance of common stock through exercise of stock options (in shares) 55,694              
Issuance of common stock through exercise of warrants $ 2   990         992
Issuance of common stock through exercise of warrants (in shares) 17,889              
Share-based compensation expense $ 4   622,060         622,064
Share based compensation expense (shares) 44,129              
Issuance of warrants in connection with debt     49,072         49,072
Net loss       (8,961,815)       (8,961,815)
Balance at the end (in shares) at Dec. 31, 2021 8,733,479              
Balance at the end at Dec. 31, 2021 $ 873 $ (172) 67,810,289 (38,019,402)       $ 29,791,588
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury stock (in shares)   31,000           31,000
Issuance of common stock in exchange for services     6,250         $ 6,250
Issuance of common stock in exchange for services (in shares) 1,000              
Issuance of common stock through exercise of stock options $ 8   78,633         78,641
Issuance of common stock through exercise of stock options (in shares) 81,043              
Share-based compensation expense     642,077         642,077
Vesting of restricted stock units $ 11   36,525         36,536
Vesting of restricted stock units (in shares) 110,286              
Net loss       (10,245,922)       (10,245,922)
Balance at the end (in shares) at Dec. 31, 2022 8,925,808              
Balance at the end at Dec. 31, 2022 $ 892 $ (172) $ 68,573,774 $ (48,265,324)       $ 20,309,170
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury stock (in shares)   31,000           31,000